[1] |
LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo.
Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
|
[2] |
ZHAO Xiaoxiao, XIE Yanming, WANG Lianxin.
Clinical applications of elemene emulsion injection in the treatment of lung cancer in the real world based on association rules
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 940-946.
|
[3] |
ZHANG Xiaomeng, LYU Jintao, ZHANG Bing, LIN Zhijian, LIU Rongxue.
Risk assessment and pre-warning of injection within Bufonis Venenum in the treatment of liver cancer
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 469-474.
|
[4] |
WANG Dan, WU Chen, REN Jingtian.
Risk analysis of dextromethorphan abuse
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1097-1099.
|
[5] |
HUANG Lihong, CHEN Feng.
Statistical considerations for real world studies supporting new drug registrations
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 27-31.
|
[6] |
HE Xuan, WANG Xiao, DAI Huizhen, LI Xin, HAN Feng.
Usage of New Anti-cancer Drugs in Nanjing from 2018 to 2020
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(8): 725-730.
|
[7] |
HUANG Zhengkai, LIN Zhijian, WANG Yu, GUO Fanfan, ZHANG Bing.
The research on Mechanism and Risk Warning of Melanosis Coli Caused by Emodin
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(8): 753-759.
|
[8] |
WANG Yu, LIN Zhijian, JIANG Zhuoxi, YANG Ting, WANG Xiao, ZHANG Bing.
Early Warning of Aconitum Herbs in Breast Cancer Therapy by Bibliometric and Bioinformatics
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 655-662.
|
[9] |
ZOU Lina, LIN Zhijian, ZHANG Xiaomeng, ZHANG Bing, HUANG Zhengkai.
Early Warning of Risks of Statins in Atherosclerosis Therapy Based on Bioinformatics
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 184-189.
|
[10] |
YANG Le, TIAN Chunhua, XIA Dongsheng, DON Duo, FAN Rong, ZHANG Meiling.
Discussion on the Monitoring and Analysis of Cluster Adverse Drug Events by Drug Marketing Authorization Holders
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 940-943.
|
[11] |
MAO Qiuyue, LIN Zhijian, WANG Yu, ZHANG Bing, SA Yi.
Early Warning of Risks of Sennae Folium to Constipation Patients with Breast Cancer by Bioinformatics
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 30-37.
|
[12] |
ZHANG Xialan, SHEN Xikun, Huang Yuyu.
Clinical Analysis of 130 Cases of Drug-induced Liver Injury in Cancer Patients
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 589-593.
|
[13] |
HUANG Yuan, WANG Chenggang, WU Shifu, WANG Ling, TIAN Yuejie, WU Chen, WANG Xiaojun.
Drug Abuse Monitoring Models in Medical Institutions in China
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 607-612.
|
[14] |
YANG Ping, AN Wei, CHEN Min, XIA Fei, XU Xin, LIAO Yaling, ZHOU Qin, LI Kuangyu, FANG Shasha, ZHANG Mingwei.
Analysis of Use of Antibacterial Drugs in 110 Discharged Patients with COVID-19
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(6): 338-341.
|
[15] |
WANG Jiayu, YU Dandan, LI Ming, WANG Ling, LIU Pengcheng, SUN Jun.
Current Abuse/Use of Compound Tramadol in Drug Abusers
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(2): 98-105.
|